Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Sumitomo Dainippon Pharma Co (4506) vs. Competitors

7 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
JP:4506Sumitomo Dainippon Pharma CoJPY 1,893.50JPY 849.41B17.77-22.78%Moderate BuyUnlock the JP:4506 analyst price target with TipRanks PremiumJP:4506Unlock the JP:4506 top-analyst price target with TipRanks Premium
JP:4523Eisai CoJPY 5,240.00JPY 1.48T33.8914.44%―Unlock the JP:4523 analyst price target with TipRanks PremiumJP:4506 vs JP:4523Unlock the JP:4523 top-analyst price target with TipRanks Premium
JP:4547Kissei Pharmaceutical CoJPY 4,455.00JPY 181.97B16.555.69%HoldUnlock the JP:4547 analyst price target with TipRanks PremiumJP:4506 vs JP:4547Unlock the JP:4547 top-analyst price target with TipRanks Premium
JP:4507Shionogi & CoJPY 3,175.00JPY 2.79T11.2217.33%Moderate BuyUnlock the JP:4507 analyst price target with TipRanks PremiumJP:4506 vs JP:4507Unlock the JP:4507 top-analyst price target with TipRanks Premium
JP:4502Takeda Pharmaceutical CoJPY 6,869.00JPY 10.96T28.1858.05%Strong BuyUnlock the JP:4502 analyst price target with TipRanks PremiumJP:4506 vs JP:4502Unlock the JP:4502 top-analyst price target with TipRanks Premium
JP:4516Nippon Shinyaku Co., Ltd.JPY 3,377.00JPY 227.45B7.69-4.20%HoldUnlock the JP:4516 analyst price target with TipRanks PremiumJP:4506 vs JP:4516Unlock the JP:4516 top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
JP:4506Sumitomo Dainippon Pharma Co1893.50-808.50-29.92%
JP:4523Eisai Co5240.00703.5515.51%
JP:4547Kissei Pharmaceutical Co4455.00316.017.63%
JP:4507Shionogi & Co3175.00520.9119.63%
JP:4502Takeda Pharmaceutical Co6869.002569.4759.76%
JP:4516Nippon Shinyaku Co., Ltd.3377.00-141.93-4.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts